Skip to content
akaturk Academic measurement
2025 SJR Q1 JCR Q2 · 3,2 7 matched articles SCIE

Journal detail

American Journal of Cardiovascular Drugs

Country
Switzerland · Western Europe
Type
journal
ISSN
  • 11753277
  • 1179187X
Scopus 0,952 SJR
Scopus Q1 SJR Q
WoS Q2 JCR Q
WoS 3,2 JIF
Scopus 66 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,952
  • Quartile Q1
  • H-Index 66
  • Cites/doc 3,39
  • Docs (3y) 188
  • Cites (3y) 604

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q2
  • JIF 3,2
  • 5Y JIF 2,8
  • JCI 0,64

WoS indexes

  • SCIE

Subject classification

Categories (SJR)

  • Cardiology and Cardiovascular Medicine Q1
  • Medicine (miscellaneous) Q1
  • Pharmacology (medical) Q1

Areas

  • Medicine

WoS categories

  • Cardiac & Cardiovascular System | Pharmacology & Pharmacy

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q1 Q2 0,952 3,2 2,8 0,64 Q2 66
2024 Q2 Q2 0,876 3 2,7 0,68 Q2 63
2023 Q2 Q2 0,79 2,8 2,6 0,7 Q2 63
2022 Q2 Q3 0,841 3 2,9 0,64 Q2 63
2021 Q1 Q3 1,01 3,3 3,1 0,76 Q2 63
2020 Q1 Q2 1,063 3,6 3,1 0,76 Q2 63
2019 Q2 Q2 0,854 2,7 2,4 0,73 Q2 63
2018 — Q2 — 2,6 2,3 0,71 Q2 —
2017 Q1 Q2 0,951 2,7 2,5 0,79 Q2 63
2016 Q1 Q2 0,927 2,8 2,5 — — 63
2015 Q1 Q2 0,92 2,2 2,1 — — 63
2014 Q1 Q2 0,992 2,4 2,1 — — 63
2013 Q1 Q3 0,957 2,2 1,9 — — 63
2012 Q2 Q3 0,761 2,1 1,9 — — 63
2011 Q2 Q3 0,757 1,8 — — — 63
2010 Q2 Q2 0,709 2 — — — 63
2009 — Q2 — 2 — — — —

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 Q2 86/237
2025 PHARMACOLOGY & PHARMACY SCIE Q2 Q2 156/356
2024 CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 Q2 76/231
2024 PHARMACOLOGY & PHARMACY SCIE Q2 Q2 138/352
2023 CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 Q2 79/222
2023 PHARMACOLOGY & PHARMACY SCIE Q2 Q2 158/354
2022 CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q3 Q2 72/143
2022 PHARMACOLOGY & PHARMACY SCIE Q3 Q2 157/278
2021 CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q3 Q2 73/143
2021 PHARMACOLOGY & PHARMACY SCIE Q3 Q2 159/279
2020 CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 Q2 62/142
2020 PHARMACOLOGY & PHARMACY SCIE Q2 Q2 130/276
2019 CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 Q2 60/138
2019 PHARMACOLOGY & PHARMACY SCIE Q3 Q2 137/271
2018 CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 Q2 62/136
2018 PHARMACOLOGY & PHARMACY SCIE Q3 Q2 135/267
2017 CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 Q2 57/128
2017 PHARMACOLOGY & PHARMACY SCIE Q2 Q2 115/261
2016 CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 — 54/126
2016 PHARMACOLOGY & PHARMACY SCIE Q2 — 107/257
2015 CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 — 61/124
2015 PHARMACOLOGY & PHARMACY SCIE Q3 — 134/255
2014 CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 — 53/123
2014 PHARMACOLOGY & PHARMACY SCIE Q2 — 122/255
2013 CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q3 — 63/125
2013 PHARMACOLOGY & PHARMACY SCIE Q3 — 130/256
2012 CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q3 — 64/124
2012 PHARMACOLOGY & PHARMACY SCIE Q3 — 144/261
2011 CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q3 — 64/117
2011 PHARMACOLOGY & PHARMACY SCIE Q3 — 162/261
2010 CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 — 55/114
2010 PHARMACOLOGY & PHARMACY SCIE Q3 — 140/252
2009 CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 — 47/95
2009 PHARMACOLOGY & PHARMACY SCIE Q3 — 141/237